Agfa-Gevaert NV (EBR:AGFB)
Belgium · Delayed Price · Currency is EUR 0.4720
+0.0080 (1.72%)
Aug 31, 2026, 5:35 PM CET
Agfa-Gevaert NV Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,075 | 1,086 | 1,138 | 1,150 | 1,145 | 1,760 |
Revenue Growth | -4.44% | -4.57% | -1.04% | 0.44% | -34.94% | 2.98% |
Gross Profit Gross Profit Growth | 325 | 328 | 354 | 358 | 345 | 497 |
Operating Income Operating Income Growth | -35 | -8 | -5 | -15 | -47 | 6 |
Net Income Net Income Growth | -108 | -71 | -92 | -102 | -221 | -17 |
Earnings Per Share EPS Growth | -0.74 | -0.46 | -0.60 | -0.66 | -1.41 | -0.11 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Healthcare IT Healthcare IT Growth | 219 | 232 | 242 | 249 | 244 | 219 |
Digital Print and Chemicals Digital Print and Chemicals Growth | 471 | 467 | 438 | 409 | 372 | 330 |
Radiology Solutions Radiology Solutions Growth | - | 317 | 383 | 425 | 461 | 464 |
CONOPS (former Offset Solutions) CONOPS (former Offset Solutions) Growth | - | 70 | 75 | 68 | 68 | 748 |
Total Total Growth | 1,075 | 1,086 | 1,138 | 1,151 | 1,145 | 1,761 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 68 | 91 | 68 | 77 | 139 | 400 |
Total Debt Total Debt Growth | 195 | 169 | 156 | 83 | 66 | 73 |
Net Cash (Debt) Net Cash Growth | -127 | -78 | -88 | -6 | 73 | 327 |
Net Cash Growth | - | - | - | - | -77.68% | -36.01% |
Net Cash Per Share Net Cash Per Share Growth | -0.87 | -0.50 | -0.57 | -0.04 | 0.47 | 1.98 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 38 | 63 | -4 | -30 | -100 | -116 |
Capital Expenditures CapEx Growth | -31 | -34 | -45 | -34 | -33 | -26 |
Free Cash Flow Free Cash Flow Growth | 7 | 29 | -49 | -64 | -133 | -142 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 30.23% | 30.20% | 31.11% | 31.13% | 30.13% | 28.24% |
Operating Margin | -3.26% | -0.74% | -0.44% | -1.30% | -4.11% | 0.34% |
Pretax Margin | -8.56% | -5.16% | -6.68% | -3.13% | -13.71% | 0.11% |
Profit Margin | -10.05% | -6.54% | -8.08% | -8.87% | -19.30% | -0.97% |
FCF Margin | 0.65% | 2.67% | -4.31% | -5.56% | -11.62% | -8.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 7.57 | 48.33 | 213.60 | 13.07 | 18.41 | 25.47 |
P/FCF Ratio | 10.26 | 2.69 | - | - | - | - |
PS Ratio | 0.07 | 0.07 | 0.10 | 0.20 | 0.36 | 0.35 |